← Back to Search

Antibiotic

Topical antibiotic for Age-Related Macular Degeneration

N/A
Waitlist Available
Led By Jason Hsu, MD
Research Sponsored by Mid Atlantic Retina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ability to provide written informed consent and comply with study assessments for the full duration of the study.
Have been diagnosed with neovascular AMD, CRVO or BRVO.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up prior to each of your eye injections for the first 4 injections and continue through the completion of your fourth injection, an anticipated maximum of 6 months.
Awards & highlights

Study Summary

This is a research study to evaluate the effects of repeated intravitreal injections on bacteria around the eye.

Eligible Conditions
  • Age-Related Macular Degeneration
  • Branch Retinal Vein Occlusion
  • Central Retinal Vein Occlusion
  • Choroidal Neovascularization

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~prior to each of your eye injections for the first 4 injections and continue through the completion of your fourth injection, an anticipated maximum of 6 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and prior to each of your eye injections for the first 4 injections and continue through the completion of your fourth injection, an anticipated maximum of 6 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determine if conj bacterial flora demonstrates increased antibiotic resistance if topical antibiotic used pre and post injection vs not used.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Topical antibioticExperimental Treatment1 Intervention
Patients will be randomized in a 1:1 fashion to receive a drop of topical antibiotic before and after the intravitreal injection in the +ABX arm (in addition to the typical prep with betadine).
Group II: No Antibiotic ArmExperimental Treatment1 Intervention
No topical antibiotics in the -ABX arm (only the typical prep with betadine)

Find a Location

Who is running the clinical trial?

Mid Atlantic RetinaLead Sponsor
13 Previous Clinical Trials
629 Total Patients Enrolled
Jason Hsu, MDPrincipal InvestigatorMid Atlantic Retina
9 Previous Clinical Trials
269 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye
Michele Formoso 2011. "A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01531842.
All > Cte
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top